e-learning
resources
Virtual 2021
06.09.2021
Adult cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience
K. Dave (London, United Kingdom), R. Dunk (London, United Kingdom), S. Madge (London, United Kingdom), V. Gerovasili (London, United Kingdom), A. Reed (London, United Kingdom), N. Simmonds (London, United Kingdom)
Source:
Virtual Congress 2021 – Adult cystic fibrosis
Session:
Adult cystic fibrosis
Session type:
Oral Presentation
Number:
1500
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Dave (London, United Kingdom), R. Dunk (London, United Kingdom), S. Madge (London, United Kingdom), V. Gerovasili (London, United Kingdom), A. Reed (London, United Kingdom), N. Simmonds (London, United Kingdom). Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience. 1500
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data.
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021
Treatment changes, readmission rates and mortality in a COPD hospital at home scheme
Source: Eur Respir J 2005; 26: Suppl. 49, 286s
Year: 2005
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database
Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020
Year: 2021
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data
Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019
Year: 2019
10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
A dedicated COPD team reduces mortality in patients with type 2 respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 312s
Year: 2004
Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP?
Source: Eur Respir J 2004; 23: 103-105
Year: 2004
A clinical scoring algorithm to predict respiratory admissions and mortality in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 75s
Year: 2007
Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Two year mortality of COPD in primary care in Greece: An observational study
Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Year: 2011
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Mortality rates for chronic lower respiratory diseases in Italy from 1979 to 2010: an age–period–cohort analysis
Source: ERJ Open Res 2016
Year: 2016
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study
Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020
Year: 2021
An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept